Open AccessDirect renin inhibitor in the treatment of paroxysmal atrial fibrillation
Author(s) -
B. A. Tatarsky,
N. V. Kazyonova,
N. V. Serebryakov
Publication year - 2010
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2010-16-1-74-81
Subject(s) - atrial fibrillation , medicine , cardiology , paroxysmal atrial fibrillation , risk factor
Atrial fi brillation is the most common heart rhythm disturbance. Hypertension is a well-established risk factor for many cases of atrial fi brillation, but its predictors are still unknown. The available treatment approaches for atrial fi brillation management are characterized by limited effectiveness and high risk of side effects, thus encouraging researches for new studies. Better understanding of the mechanisms leads to the development of new therapy approaches. This paper presents the results of the study of atrial fi brillation prevention in hypertensive patients getting direct renin inhibitor.